COLL vs SOFI · P/E 17, rev $181.9M vs P/E 39, rev $619.4M
Collegium Pharmaceutical Inc (COLL) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the COLL and SOFI stock pages for the full models.
Not investment advice.